This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Sprint, CombinatoRx: Early Volume Plays

Stocks in this article: S CRXX

NEW YORK ( TheStreet) -- Several stocks trading under $5 were poised to move on above-average volume during Monday's session.

Nabi Biopharmaceuticals (NABI) surged by $1.19, or 33.4%, to $4.75 in the premarket session after the company and GlaxoSmithKline (GSK) announced a global option and licensing agreement for NicVAX, an investigational vaccine for the treatment of nicotine addiction and the prevention of smoking relapse, as well as for the development of a second generation nicotine vaccine. The 50-day average daily volume for Nabi is 179,000, according to the Nasdaq.

Netlist (NLST) jumped by 53 cents, or 11.9%, to $5 in the premarket session ahead of the Supercomputing 2009 conference in Portland, Oregon, where the company will introduce HyperCloud, the first 16-gigabyte, 2 vRank memory module for computer servers. The 50-day average daily volume for Netlist is 368,000, according to the Nasdaq.

China Advanced Construction Materials Group (CADC) dropped by $1.51, or 23.2%, to $5 in the premarket session after the company posted fiscal first-quarter adjusted earnings of 18 cents a share, although including a change in fair value of warrants, it would have lost 44 cents a share. Additionally, the company said it burned through $1.44 million in cash during the quarter. The three-month average daily volume for China Advanced is 19,000, according to Yahoo! Finance.

Sprint Nextel (S) rose by 26 cents, or 8.4%, to $3.36 in the premarket session after Credit Suisse upgraded the company's stock to outperform from neutral. The firm also raised its stock price target to $6 from $4 and added it to the U.S Focus List. The move comes as Credit Suisse said risks are mostly past the company, and that margin trends and subscriber numbers should improve in 2010. The three-month average daily volume for Sprint is 55.5 million, according to Yahoo! Finance.

CombinatoRx (CRXX) plummeted by 73 cents, or 44.8%, to 90 cents in the premarket session after the company and privately-held Neuromed Pharmaceuticals said the Food and Drug Administration indicated that a new drug application in its current form would not be sufficient to form the basis for approval of Exalgo, a treatment for moderate to severe pain in opioid tolerant patients. The 50-day average daily volume for CombinatoRx is 842,000, according to the Nasdaq.

Spherix (SPEX) jumped by $1.39, or 69.5%, to $3.39 in the premarket session after the company announced "positive interim results" in Phase 3 trial of its Naturlose treatment for Type 2 Diabetes. Spherix said it remains on target to complete the late-stage trial and submit a new drug application next year. The 50-day average daily volume for Spherix is 53,000, according to the Nasdaq.

-- Written by Robert Holmes in New York.

Check out all of Monday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on Twitter and become a fan of on Facebook.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs